Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

Abroad (travel likely)Recruiting

Conditions

Atypical Alzheimer's Disease · Logopenic Progressive Aphasia (LPA) · Posterior Cortical Atrophy (PCA) · Alzheimer Disease · Alzheimer Disease, Early Onset · Amnestic Disorder · Amnestic Symptoms · Amnestic Mild Cognitive Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic, Rochester, Minnesota, United States
Contact: Study coordinator (Sarah Boland, CCRP) · boland.sarah@mayo.edu · 507-284-3863

Study leads

Jennifer Whitwell, Ph.D.
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Swedish BioFINDER 2 Study

Dementia · Alzheimer Disease · Parkinson Disease

Abroad (travel likely)Recruiting

Ängelholm, Sweden · Malmö, Sweden

PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

Frontotemporal Lobar Degeneration · Alzheimer Disease · Cognitively Normal

Abroad (travel likely)RecruitingPHASE3

Philadelphia, United States

Proteinopathies Expression in Skin of Neurodegenerative Disorders

Alzheimer Disease · Frontotemporal Dementia · Parkinson Disease

Abroad (travel likely)Recruiting

San Luis Potosí City, Mexico

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Neurodegenerative Diseases · Parkinson Disease · Synucleinopathies

Abroad (travel likely)Recruiting

Cassino, Italy